SpringerLink
Log in

Cell-Mediated Immunity against Varicella-Zoster Virus

  • Chapter
Herpesviruses and Immunity

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

  • 128 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arvin, A. M., 1995, Varicella-zoster virus, in: Virology, (B. N. Fields, ed.), Raven Press, New York, pp. 2547–2586.

    Google Scholar 

  2. Moffat, J. F., Stein, M. D., Kaneshima, H., and Arvin, A. M., 1995, Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice, J. Virol 69(9):5236–5242.

    PubMed  CAS  Google Scholar 

  3. Arvin, A. M., 1992, Cell-mediated immunity to varicella-zoster virus, ℑ. Infect. Dis. S35–41.

    Google Scholar 

  4. Cohen, J., and Straus, S. E., 1995, Varicella zoster virus and its replication. In Virology (B. N. Fields, ed.), Raven Press, New York, pp. 2525–2546.

    Google Scholar 

  5. Gershon, A. A., 1995, Varicella vaccine: Its past, present and future, Pediatr. Infect. Dis. J. 14(9):742–744.

    PubMed  CAS  Google Scholar 

  6. Arvin, A. M., and Gershon, A. A., 1996, Live attenuated varicella vaccine, Ann. Rev. Microbiol. 50:59–100.

    Article  CAS  Google Scholar 

  7. Takahashi, M., and Gershon, A., Live attenuated varicella vaccine, in: Vaccines (M. Levine, ed.).

    Google Scholar 

  8. Clarke, P., Beer, T., Cohrs, R., and Gilden, D. H., 1995, Configuration of latent varicella-zoster virus DNA, ℑ. Virol. 69(12):8151–8154.

    CAS  Google Scholar 

  9. Davison, A. J., and Scott, J. E., 1986, The complete DNA sequence of varicella-zoster virus. ℑ. Gen. Virol. 67:1759–1816.

    CAS  Google Scholar 

  10. Gray, W. L., Pumphrey, C. Y., Ruyechan, W. T., and Fletcher, T. 51., 1992, The simian varicella virus and varicella-zoster virus genomes are similar in size and structure, Virology 186(2):562–572.

    Article  PubMed  CAS  Google Scholar 

  11. Moriuchi, H., Moriuchi, M., Dean: H., Cheung, A. K., and Cohen, J. I., 1995, Pseudorabies virus EPO is functionally homologous to varicella-zoster virus ORF6 1 protein and herpes simplex virus type 1, Virology 209:281–283.

    Article  PubMed  CAS  Google Scholar 

  12. Takada, M., Suzutani, T., Yoshida, I., Matoba, M., and Azuma, M., 1995, Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site less region, Clin. ℑ. Microbiol. 33(3):658–660.

    CAS  Google Scholar 

  13. LaRussa, P., Lungu, O., Hardy, I., Gershon, A, Steinberg, S. P., and Silverstein, S., 1994, Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates, J Virol. 66(2): 1016–1020.

    Google Scholar 

  14. Forghani, B., Yu, G. J., and Hurst, J. W., 1991, Comparison of biotinylated DSA and RSA probes for rapid detection of varicella-zoster virus genome by in situ hybridization, ℑ. Clin. Microbiol. 29(3):583–591.

    CAS  Google Scholar 

  15. Koropchak, C. M., Solem, S. M., Diaz, P. S., and Arvin, A. M., 1989, Investigation of varicellazoster virus infection of lymphocytes by in situ hybridization, J. Virol, 63(5):2392–2395.

    PubMed  CAS  Google Scholar 

  16. Koropchak, C. M., Graham, G., Palmer, J., et al. 1991, Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella [published erratum appears in J Infect. Dis. 165(1):188, 1992l. ℑ. Infect. Dis. 163(5):1016–1022.

    CAS  Google Scholar 

  17. Sawyer, M. H., Wu, Y. N., Chamberlain, C. J., et al., 1992, Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella, J. Infect. Dis. 166(4):885–888.

    PubMed  CAS  Google Scholar 

  18. Cohen, J. I., and Seidel, K. E., 1995, Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro Virology 206(2):835–842.

    Article  PubMed  CAS  Google Scholar 

  19. Kemble, 1996, personal communication.

    Google Scholar 

  20. Grose, C., I991, Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs, Rev. Infect. Dis. 16:S960–S963.

    Google Scholar 

  21. Davison, A., Edson, C., Ellis, R., et al., 1986, New common nomenclature for glycoprotein genes of varicella-zoster virus and their products, J. Virol. 57:1195–1197.

    PubMed  CAS  Google Scholar 

  22. Forghani, B., Ni, L., and Grose, C., 1994, Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex, Virology 199(2):458–462.

    Article  PubMed  CAS  Google Scholar 

  23. Yao, Z., Jackson, CV., Forghani, B., and Grose, C., 1993, Varicella-zoster virus glycoprotein gpI/gpIV receptor: Expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system, J. Virol. 67(1):305–314.

    PubMed  CAS  Google Scholar 

  24. Zhu, Z., Gershon, M. D., Ambron, R., Gabel, C., and Gershon, A. A., 1995, Infection of cells by varicella-zoster virus: Inhibition of viral entry by mannose 6-phosphate and heparin, Proc. Natl. Acad. Sci. USA 92(8):3546–3550.

    PubMed  CAS  Google Scholar 

  25. Gabel, C. A., Dubey, L., Steinberg, S. P., Sherman, D., Gershon, M. D., and Gershon, A. A., 1989, Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during post-translational maturation, J Virol 63(10):4264–4276.

    PubMed  CAS  Google Scholar 

  26. Gershon, A. A., Sherman, D. L., Zhu, Z., Gabel, C. A., Ambron, R. T., and Gershon, M. D., 1994, Intracellular transport of newly synthesized varicella-zoster virus: Final envelopment in the trans-Golgi network, ℑ. Virol. 68(10):6372–6390.

    CAS  Google Scholar 

  27. Mallory, S., and Arvin, A. M., 1997, Mutational analysis of varicella-zoster virus (VZV) glycoproteins, gI and gE, in recombinant VZV strains, in preparation.

    Google Scholar 

  28. Cohen, J. I., and Seidel, K. E., 1994, Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin, ℑ. Gen. Virol. 59:3087–3093.

    Google Scholar 

  29. Kinchington, P. R., Ling, P., Pensiero, M., Moss, B., Ruyechan, W. T., and Hay, J., 1990, The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka), J. Virol. 64(9):4540–4548.

    PubMed  CAS  Google Scholar 

  30. Rodriguez, J. E., Moninger, T., and Grose, C., 1993, Entry and egress ofvaricella virus blocked by same anti-gH monoclonal antibody, Virology 196(2):840–844.

    Article  PubMed  CAS  Google Scholar 

  31. Cohen, J. I., and Seidel, K., 1994, Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro, ℑ. Virol. 68 (12):7850–7858.

    CAS  Google Scholar 

  32. Debrus, S., Sadzot, D. C., Nikkels, A. F., Piette, J., and Rentier, B., 1995, Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency, J Virol. 69(5):3240–3245.

    PubMed  CAS  Google Scholar 

  33. Kinchington, P. R., Bookey, D., and Turse, S. E., 1995, The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles, ℑ. Virol. 69(7):4274–4282.

    CAS  Google Scholar 

  34. Takahashi, M., 1986, Clinical overview of varicella vaccine: Development and early studies, Pediatrics7883 736–741

    Google Scholar 

  35. Arvin, A., Kinney-Thomas, E., Shriver, K., et al., 1986, Immunity to varicella-zoster glycoproteins, gpI (gp 90/58) and gp III (gp 118), and to a nonglycosulated protein, p170. ℑ. Immunol. 137:1346–1351.

    CAS  Google Scholar 

  36. Giller, R. H., Winistorfer, S., and Grose, C., 1989, Cellular and humoral immunity to varicellazoster virus glycoproteins in immune and susceptible human subjects, Infect. Dis. 160(6):919–928.

    CAS  Google Scholar 

  37. Bergen, R. E., Sharp, M., Sanchez, A., Judd, A. K., and Arvin, A. M., 1991, Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella-zoster virus, Viral Immunol. 4(3):151–166.

    Article  PubMed  CAS  Google Scholar 

  38. Hayward, A. R., 1990, T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV, J. Virol. 64(2):651–655.

    PubMed  CAS  Google Scholar 

  39. Arvin, A. M., 1996, Immune responses to varicella-zostervirus, in: Infectious Disease Clinics of North America, Vol. 10, (R. W. Ellis, C. W., ed.), W. B. Saunders, Philadelphia, pp. 529–570.

    Google Scholar 

  40. Hayward, A., and Herberger, M., 1987, Lymphocyte responses to varicella-zoster in the elderly, J. Clin. Immunol. 7:174–178.

    Article  PubMed  CAS  Google Scholar 

  41. Arvin, A. M., Sharp, M., Smith, S., et al., 1991, Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype, J Immunol. 146(l):257–264.

    PubMed  CAS  Google Scholar 

  42. Diaz, P. S., Smith, S., Hunter, E., and Arvin, A. M., 1989, T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine, J. Immunol., 142(2):636–641.

    PubMed  CAS  Google Scholar 

  43. Hayward, A., Pontesilli, O., Herberger, M., Laszlo, M., and Levin, M., 1986, Specific lysis of varicella-zoster virus-infected B lymphoblasts by human T cells, J Virol. 58: 179–184.

    PubMed  CAS  Google Scholar 

  44. Hickling, J. K., Borysiewicz, L. K., and Sissons, J. G., 1987, Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): Detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood, J Infect. Dis. 156(5):3463–3469.

    Google Scholar 

  45. La Russa, P., Steinberg, S., Seeman, M. D., and Gershon, A. A., 1985, Determination of immunity to varicella by means of an intradermal skin test, J. Infect. Dis. 152:869–875.

    Google Scholar 

  46. Asano, Y., Shiraki, K., Takahashi, M., Nagai, T., et al., 1981, Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures, J. Infect. Dis. 143:684–692.

    PubMed  CAS  Google Scholar 

  47. Jenkins, D., and Arvin, A. M., 1997, Primary T-cell responses to the varicella-zoster virus immediate early protein, IE62 elicited in vitro by dendritic cell presentation, in preparation.

    Google Scholar 

  48. Grose, C. H., 1984, Variation on a theme by Fenner, Pediatrics, 68:735–737.

    Google Scholar 

  49. Ozaki, T., Masuda, S., Asano, Y., Kondo, K., Namazue, J., and Yamanishi, K., 1994, Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination, J. Med. Virol. 42(l):47–51.

    PubMed  CAS  Google Scholar 

  50. Perera, L. P., Mosca, J. D., Ruyechan, W. T., and Hay, J., 1992, Regulation of varicella-zoster virus gene expression in human T lymphocytes [published erratum appears in 3. Virol., 69(4):2723, 19951. J Virol. 66(9):5298–5304.

    Google Scholar 

  51. Ross, A. H., Lencher, E., and Reitman, G., 1962, Modification of chicken pox in family contacts by administration of gamma globulin, N. Engl. ℑ. Med. 267:369–376.

    CAS  Google Scholar 

  52. Bowden, R. A., Levin, M. J., Giller, R. H., Tubergen, D. G., and Hayward, A. R., 1985, Lysis of varicella-zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients, Clin. Exp. Immunol. 60:387–395.

    PubMed  CAS  Google Scholar 

  53. Ihara, T., Starr, S., Ito, M., Douglas, S., and Arbeter, A., 1984, Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fiborblasts, J Virol. 51:110–116.

    PubMed  CAS  Google Scholar 

  54. Arvin, A. M., Kushner, J. H., Feldman, S., Baehner, R. L., Hammond, D., and Merigan, T. C., 1982, Human leukocyte interferon for the treatment ofvaricella in children with cancer, N. Engl. J Med. 306:761–765.

    Article  PubMed  CAS  Google Scholar 

  55. Arvin, A. M., Koropchak, C. M., Williams, B. R., Grumet, F. C., and Foung, S. K., 1986, Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection, J.Inect. Dist. 154:422–429.

    CAS  Google Scholar 

  56. Wallace, M. R., Woelfl, I., Bowler, W. A., et al., 1994, Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella, J. Med. Virol. 43(1):69–71.

    PubMed  CAS  Google Scholar 

  57. Kinchington, P. R., Hougland, J. K., Arvin, A. M., Ruyechan, W. T., and Hay, J., 1992, The varicella-zoster virus immediate-early protein IE62 is a major component of virus particle, 3. Virol. 66(1):359–366.

    CAS  Google Scholar 

  58. Sharp, M., Terada, K., Wilson, A., et al., 1992, Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuate varicella vaccine, J.Infect. Dis. 165(5):852–858.

    PubMed  CAS  Google Scholar 

  59. Gershon, A., and Steinberg, S., 1982, Cellular and humoral immune responses to VZV in immunocompromised patients during and after VZV infections, Infect. Immun. 1979;25:828.

    Google Scholar 

  60. Patel, P. A., Yoonessi, S., O’Malley, J., Freeman, A., Gershon, A., and Ogra, P. L., 1979, Cell-mediated immunity to varicella-zoster virus in subjects with lymphoma or leukemia, J. Pediatr. 94:223–230.

    PubMed  CAS  Google Scholar 

  61. Straus, S. E., Ostrove, J. M., Inchauspe G., et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intem Med 1988;109:438–439.

    Google Scholar 

  62. Gilden, D. H., Mahalingam, R., Dueland, A. N., Cohrs, R., 1992, Herpes zoster: pathogenesis and latency. Prog. Med. Virol. 39(19):19–75.

    PubMed  CAS  Google Scholar 

  63. Lungu, O., Annunziato, P. W., Gershon, A., et al, 1995, Reactivated and latent varicella-zoster virus in human dorsal root ganglia, Proc. Natl. Acad. Sci. USA 92(24):10980–10984.

    PubMed  CAS  Google Scholar 

  64. Straus, S. E., 1994, Overview: The biology of varicella-zoster virus infection, Ann. Neurol. 56: S4–8.

    Google Scholar 

  65. Gilden, D. H., Rozenman, Y., Murray, R., Devlin, M., and Vafai, A., 1987, Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia, Ann. Emerging Med. 16(9):377–380.

    Google Scholar 

  66. Sadzot, D. C., Debrus, S., Nikkels, A., Piette, J., and Rentier, B., 1995, Varicella-zoster virus latency in the adult rat is a useful model for human latent infection, Neurology 45:S18–20.

    Google Scholar 

  67. Zhang, Y., Cosyns, M., Levin, M. J., and Hayward, A. R., 1994, Cytokine production in varicella-zoster virus-stimulated limiting dilution lymphocyte cultures, Clin. Exp. Immunol. 98(1):128–133.

    PubMed  CAS  Google Scholar 

  68. Sadzot-Delvaux, C., Kinchington, P., Debrus, S., Rentier, B., and Arvin, A. M., 1997, Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T-lymphocytes, J Immunol. 150:2802–2806.

    Google Scholar 

  69. Huang, Z., Vafai, A., Lee, J., Mahalingam, R., and Hayward, A. R., 1992, Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones, J. Virol. 66(5):2664–2669.

    PubMed  CAS  Google Scholar 

  70. Arvin, A. M., Pollard, R. B., Rasmussen, L., and Merigan, T., 1980, Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma, 3. Clin. Invest. 65:869–878.

    CAS  Google Scholar 

  71. Meyers, J. D., Flurnoy, N., and Thomas, E. D., 1980, Cell-mediated immunity to varicellazoster virus after allogeneic bone marrow transplantation, J Infect. Dis. 141:479–487.

    PubMed  CAS  Google Scholar 

  72. Berger, R., Florent, G., and Just, M., 1981, Decrease of the lympho-proliferative response to varicella-zoster virus antigen in the aged, Infect. Immun. 32:24–27.

    PubMed  CAS  Google Scholar 

  73. Wilson, A., Sharp, M., Koropchak, C. M., Ting, S. F., and Arvin, A. M., 1992, Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation, J. Infect. Dis. 165(1):119–126.

    PubMed  CAS  Google Scholar 

  74. Terada, K., Kawano, S., Yoshihiro, K., and Morita, T., 1994, Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity afte chicken pox in infancy, ℑ. Infect. Dis. 169(3):650–652.

    CAS  Google Scholar 

  75. Arvin, A., Koropchak, C. M., and Wittek, A. E., 1983, Immunologic evidence of reinfection with varicella-zoster virus, J. Infect. Dis. 148:200–205.

    PubMed  CAS  Google Scholar 

  76. Gershon, A. A., Steinberg, S., and Gelb, L., 1984, NIAID-Collaborative-Varicella-Vaccine-Study-Group. Clinical reinfection with varicella-zoster virus, J. Infect. Dis. 149:137–142.

    PubMed  CAS  Google Scholar 

  77. Shiraki, K., Yamanishi, K., and Takahashi, M., 1983, Biological and immunological characterization of the soluble skin test antigen of varicella-zoster virus, J. Infect. Dis. 149:501–504.

    Google Scholar 

  78. Connelly, B. L., Stanberry, L. R., and Bernstein, D. I., 1993, Detection ofvaricella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella, J. Infect. Dis. 168(5):1253–1255.

    PubMed  CAS  Google Scholar 

  79. Gilden, D., Mahlingham, R., Dueland, N., and Cohrs, R., 1992, Herpes zoster: Pathogenesis and latency, Prog. Med. Virol. 39:19–75.

    PubMed  CAS  Google Scholar 

  80. Hayward, A., Levin, M., Wolf, W., Angelova, G., and Gilden, D., 1991, Varicella-zoster virus-specific immunity after herpes zoster, J. Infect. Dis. 163(4):873–875.

    PubMed  CAS  Google Scholar 

  81. Stevens, D., Ferrington, R., Jordan, G., and Merigan, T., 1975, Cellular events in zoster vesicles: Relation to clinical course and immune parameters, J. Infect. Dis. 131:509–515.

    PubMed  CAS  Google Scholar 

  82. Merigan, T. C., Rand, K., Pollard, R., Abdallah, P., Jordan, G. W., and Fried, R. P., 1978, Human leukocyte interferon for the treatment of herpes zoster in patients with cancer, N Engl. J. Med. 298:981–987.

    Article  PubMed  CAS  Google Scholar 

  83. Devlin, M. E., Gilden, D. H., Mahalingam, R., Dueland, A. N., and Cohrs, R., 1992, Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA, ℑ. Infect. Dis. 165(4):619–622.

    CAS  Google Scholar 

  84. Kuter, B. J., Ngai, A., Patterson, C. M., et al., 1995, Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group, Vaccine 13(11):967–972.

    Article  PubMed  CAS  Google Scholar 

  85. Kuter, B. J., Weibel, R. E., Guess, H. A., et al., 1991, Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies, Vaccine 9(9):643–647.

    Article  PubMed  CAS  Google Scholar 

  86. Weibel, R., Kuter, B., Neff, B., et al., 1985, Live Oka/Merck varicella vaccine in healthy children: Further clinical and laboratory assessment, JAMA 245:2435–2439.

    Google Scholar 

  87. Arbeter, A., Starr, S.E., and Plotkin, S. A., 1986, Varicella vaccine studies in healthy children and adults, Pediatrics 78(suppl):748–756.

    PubMed  CAS  Google Scholar 

  88. Asano, Y., Suga, S., Yoshikawa, T., et al., 1994, Experience and reason: Twenty year follow up of protective immunity of the Oka live varicella vaccine, Pediatrics 94:524–526.

    PubMed  CAS  Google Scholar 

  89. Watson, B., Boardman, C., Laufer, D., et al., 1995, Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine, Clin. Infect. Dis. 20(2):316–319.

    PubMed  CAS  Google Scholar 

  90. Watson, B., Piercy, S., Soppas, D., et al., 1993, The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine, ℑ. Infect. Dis. 168(6):1356–1360.

    CAS  Google Scholar 

  91. Bergen, R. E., Diaz, P. S., and Arvin, A. M., 1990, The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content, J. Infect. Dis. 162(5):1049–1054.

    PubMed  CAS  Google Scholar 

  92. Asano, Y., Yoshikawa, T., Suga, S., et al., 1993, Postexposure prophylaxis of varicella in family contact by oral acyclovir, Pediatrics 92(2):219–222.

    PubMed  CAS  Google Scholar 

  93. Watson, B., Keller, P. M., Ellis, R. W., Starr, S. E., 1994, Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: Kinetics and specificity, ℑ Infect. Dis. 162(4):794–799.

    Google Scholar 

  94. Hayward, A., Villanueba, E., Cosyns, M., and Levin, M., 1992, Varicella-zoster virus (VZv)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine, J.Infect. Dis. 166(2):260–264.

    PubMed  CAS  Google Scholar 

  95. Nader, S., Bergen, R., Sharp, M., and Arvin, A. M., 1995, Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine, J. Infect. Dis. 171(1):13–17.

    PubMed  CAS  Google Scholar 

  96. Gershon, A., LaRussa, P., and Steinberg, S., 1995, Clinical trials in immunocompromised individuals, in: Infectious Disease Clinicso fNorth America, Vol. IO, (R. E., White, ed.), Saunders, Philadelphia, pp. 583–594.

    Google Scholar 

  97. Brunell, P. A., Shehab, Z., Geiser, C., and Waugh, J. E., 1982, Administration of live varicella vaccine to children with leukemia, Lancet 2:1069–1073.

    PubMed  CAS  Google Scholar 

  98. Asano, Y., Itakura, N., Hiroishi, Y., et al., 1985, Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine, J. Infect. Dist. 152:863–868.

    CAS  Google Scholar 

  99. Watson, B., Gupta, R., Randall, T., and Starr, S., 1993, Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine, J. Infect. Dis. 169:197–199.

    Google Scholar 

  100. Gershon, A. A., La Russa, P., Hardy, I., Steinberg, S., and Silverstein, S., 1992, Varicella vaccine: The American experience, J. Infect. Dis. 166:S63–68.

    Google Scholar 

  101. White, C. J., Kuter, B. J., Hildebrand, C. S., et al., 1991, Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989 [see comments], Pediatrics 87(5):60–610.

    Google Scholar 

  102. Gershon, A. A., and Steinberg, S. P., 1990, Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group, J. Infect. Dis. 161(4):661–666.

    PubMed  CAS  Google Scholar 

  103. Gershon, A., Steinberg, S., and Gelb, L., 1986, NIAID-Collaborative-Varicella-Vaccine-Study-Group. Live attenuated varicella vaccine: Use in immunocompromised children and adults, Pediatrics 78(S):757–762.

    PubMed  CAS  Google Scholar 

  104. Zerboni, L., Nader, S., and Arvin, A. M., in press, Age-related differences in the persistence of immunity induced by varicella vaccine, J. Infect. Dis.

    Google Scholar 

  105. Gershon, A. A., Steinberg, S., and Gelb, L., 1984, NIAID-Collaborative-Varicella-Vaccine-Study-Group. Live attenuated varicella vaccine: Efficacy for children with leukemia in remission, JAMA 252:355–362.

    Article  PubMed  CAS  Google Scholar 

  106. Levin, M. J., Murray, M., Zerbe, G. O., White, C. J., and Hayward, A. R., 1994, Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine, J. Infect. Dis. 170(3):522–526.

    PubMed  CAS  Google Scholar 

  107. Levin, M. J., Murray, M., Rotbart, H. A., Zerbe, G. O., White, C. J., and Hayward, A. R., 1992, Immune response of elderly individuals to a live attenuated varicella vaccine, J. Infect. Dis. 166(2):253–259.

    PubMed  CAS  Google Scholar 

  108. Levin, M. J., Rotbart, H. A., and Hayward, A. R., 1995, Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella [letter], J. Infect. Dis. 171(5):1383–1384.

    PubMed  CAS  Google Scholar 

  109. Redman, R. L., Nader, S., Zerboni, L., et al., Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine, submitted.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Microbiology/Immunology, Stanford University School of Medicine, Stanford, California, 94305

    Ann M. Arvin

Authors
  1. Ann M. Arvin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida College of Medicine, Tampa, Florida

    Peter G. Medveczky  & Herman Friedman  & 

  2. University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Arvin, A.M. (2002). Cell-Mediated Immunity against Varicella-Zoster Virus. In: Medveczky, P.G., Friedman, H., Bendinelli, M. (eds) Herpesviruses and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46808-5_12

Download citation

  • DOI: https://doi.org/10.1007/0-306-46808-5_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45890-3

  • Online ISBN: 978-0-306-46808-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation